DeutschNewstral
Article
Sydney Morning Herald on 2021-06-18 21:00
‘There’s always a way forward’: Crunchtime for Mesoblast as legal threats loom
Related news
- Mesoblast moves to tap private wealth fundsSydney Morning Herald
- Mesoblast sees lasting need for COVID treatment beyond a vaccineSydney Morning Herald
- Mesoblast holds out hope for heart failure drugSydney Morning Herald
Lightning weigh finals hopes as threats loomtheage.com.au- Mesoblast raises $138m from investors on hopes for COVID-19 treatmentSydney Morning Herald
- Oil refiner urges swift subsidies rollout as closure threats loomSydney Morning Herald
- SComing out is not always a smooth journey — but there’s always support availablestarobserver.com.au
- Mesoblast eyes COVID-19 trial results by end of yearSydney Morning Herald
- Mesoblast stem cell therapy approved by Japanese health watchdogSydney Morning Herald
- Mesoblast takes partnership with Celgene, shares rise 27pcSydney Morning Herald
- MMesoblast suspension puts Teva links in the crosshairsm.smh.com.au
- Mesoblast posts $119m full-year loss, eyes first salesSydney Morning Herald
- 'Sweep it under the carpet': Health tech cyber threats loomSydney Morning Herald
- Mesoblast reveals more COVID trials needed, shares tumbleSydney Morning Herald
- When the economy slows, there’s always lipstick and mascaraSydney Morning Herald
- ‘There’s always big expectations’: Coolmore colts spring into actionSydney Morning Herald
- Mesoblast revenue up 90 per cent as company waits on product newsSydney Morning Herald
- PMesoblast Sept qtr loss narrowsperthnow.com.au
Do Litigation Threats Always Support A Work Product Claim?jdsupra.com- 'More tough decisions': Qantas to cut more jobs as COVID, Virgin threats loomSydney Morning Herald